The FKTN gene helps make fukutin, a protein needed to place sugar marks on another protein that helps muscle cells stay attached to nearby support tissue and supports brain and eye development. This gene plays an important role in how muscles hold up during everyday movement. If the gene does not work properly, people may have muscle weakness, delayed motor milestones, and sometimes learning, brain, or eye changes. Some variants in the FKTN gene cause Fukuyama congenital muscular dystrophy, while others lead to milder limb-girdle muscular dystrophy.
What is a gene?
Genes are sections of DNA that provide cells with instructions for making molecules or guiding processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do much of the work. Other genes mainly regulate when certain processes happen, where they occur, and how strongly they run. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To go into this topic in more detail, you can learn more in the LearnHub.
Overview
FKTNGene function
What if the gene works
The FKTN gene helps cells add sugar tags to a protein that supports muscle and brain development. This helps muscle cells stay stable and connect properly with surrounding tissue.
Risk
What if the gene does not work
Variants in the FKTN gene can weaken muscle from birth or later in life, with severity ranging from mild limb weakness to Fukuyama congenital muscular dystrophy. Some people also have brain, eye, or heart involvement.
Treatment
What does that mean for your treatment
No treatment or drug choice strategy specific to pathogenic variants in the FKTN gene is currently established. Research is exploring gene replacement and related therapies for FKTN-related muscular conditions, but these approaches are not standard care yet.
Conditions associated with FKTN
Gene function
What if the gene works
Muscle and brain cells need a steady grip on the tissue around them so they can work in an organized way. The FKTN gene helps build that grip by preparing a surface protein called alpha-dystroglycan. Understanding what the FKTN gene does helps explain how cells stay supported during everyday movement and growth.
The FKTN gene helps cells add special sugar groups to alpha-dystroglycan, a protein on the cell surface. This finishing step lets that protein take the shape it needs to do its job.
Once alpha-dystroglycan is properly prepared, it can bind more effectively to the support material outside cells. This helps anchor cells to their surroundings and supports the overall structure of tissues.
These cell-to-surface links help tissues handle ordinary mechanical stress from movement and daily use. They also help cells stay positioned and organized as muscles and other tissues grow and maintain themselves.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effects and simply represent natural genetic variation. In some situations, though, a variant can change a gene’s function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the FKTN gene can change how the protein folds or works, so it cannot fully help build the sugar coating on alpha-dystroglycan, a cell-surface anchor protein. This overview of how FKTN gene variants affect protein function focuses on reduced or absent activity, with some variants leaving partial function and others causing near-complete loss. Less disruptive variants may preserve some binding to surrounding support proteins, while more severe variants often go with earlier or more wide-ranging features in FKTN-related conditions.
How variants are linked to conditions
Pathogenic variants in the FKTN gene can cause a range of inherited muscle conditions. FKTN gene variants linked to muscular dystrophy are best known for causing Fukuyama congenital muscular dystrophy and other dystroglycan-related muscular dystrophies, including some limb-girdle forms. Depending on the variant, a person may also have developmental differences involving the brain or eyes, and some may develop heart muscle disease such as dilated cardiomyopathy.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are widely found across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, however, a single well-characterized variant in a particular gene may be enough on its own to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific lifestyle or environmental factors that increase or reduce health risks related to the FKTN gene. For many living with FKTN-related conditions, risk is shaped mainly by the exact gene change and whether one or both copies of the gene are affected.
Inheritance of FKTN variants
FKTN-related conditions are inherited in an autosomal recessive pattern. In practical terms, how variants of the FKTN gene are inherited means a child usually needs to receive one changed copy from each parent to have the condition, while parents with one changed copy are typically carriers. When both parents carry an FKTN variant, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier child, and a 25% chance of a child with two working copies. Because the FKTN gene is on chromosome 9, it can be passed on by either parent to children of any sex.
What does my FKTN result mean for my family?
For FKTN, family meaning usually centers on a recessive muscle and brain condition. If you have a disease-causing FKTN change linked to this condition, brothers and sisters could also be affected or could be healthy carriers, and parents are often carriers as well. Other relatives may also carry the same change, especially on the same side of the family.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the FKTN gene usually uses a blood or saliva sample. A lab reads the DNA code to look for changes in the FKTN gene, either with single gene testing or a broader panel, and the results can help confirm an FKTN-related diagnosis or show carrier status.
When should I consider getting a genetic test?
Consider FKTN testing if a baby or child has marked muscle weakness from early life, delayed movement milestones, or brain or eye changes along with a suspected inherited muscle condition such as Fukuyama congenital muscular dystrophy. Testing can also help when this condition runs in the family or both parents are known carriers.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they reveal varies with the condition and the kind of variant involved. Over time, the way the body functions is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, particularly those linked to many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic finding may give a clear answer. In areas like medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same treatment may work well for one person, have less effect in another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medication. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are better informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the FKTN gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or medication response, so any questions about medicines, side effects, or your overall health are best discussed with your doctor.
History
The FKTN gene entered medical history through studies of Fukuyama congenital muscular dystrophy, a condition first described in Japan in the 1960s by pediatric neurologist Yukio Fukuyama. Families and communities once noticed patterns that seemed to pass from parent to child. In 1998, researchers identified the FKTN gene as the cause in many affected families, which marked an important step in understanding this inherited muscle and brain condition. Early work also showed that one shared variant was especially common in Japan, helping explain why the condition was reported there more often than in many other countries. From these first observations, research expanded steadily. This history made the FKTN gene one of the key early examples of how careful family studies and DNA testing could solve a long-standing medical puzzle.